FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.2  |  FHIR Version n/a  User: [n/a]

387234006: Dexamethasone ophthalmic preparation (substance)

    Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2003. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    1461412015 Dexamethasone ophthalmic preparation (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
    1481337017 Dexamethasone ophthalmic preparation en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Dexamethasone ophthalmic preparation Is a Dexamethasone (substance) false Inferred relationship Some
    Inbound Relationships Type Active Source Characteristic Refinability Group
    Dexamethasone 1 mg/mL and tobramycin 3 mg/mL eye drops The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Dexamethasone ophthalmic preparation Inferred relationship Some
    Product containing dexamethasone and tobramycin (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Dexamethasone ophthalmic preparation Inferred relationship Some
    dexamethasonnatriumphosphat 0,1 % øjendråber til engangsbrug The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Dexamethasone ophthalmic preparation Inferred relationship Some
    dexamethason 0,1 % + hypromellose 0,5 % øjendråber The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Dexamethasone ophthalmic preparation Inferred relationship Some
    Dexamethasone compound eye ointment The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Dexamethasone ophthalmic preparation Inferred relationship Some
    Dexamethasone eye drops The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Dexamethasone ophthalmic preparation Inferred relationship Some
    dexamethason 0,1 % øjendråber uden konserveringsmiddel The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Dexamethasone ophthalmic preparation Inferred relationship Some
    Product containing precisely dexamethasone 1 milligram/1 milliliter conventional release eye drops (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Dexamethasone ophthalmic preparation Inferred relationship Some
    kombinationspræparat med dexamethason til topikal anvendelse The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Dexamethasone ophthalmic preparation Inferred relationship Some
    Dexamethasone sodium phospha 4mg/mL The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Dexamethasone ophthalmic preparation Inferred relationship Some
    Product containing precisely dexamethasone 1 milligram/1 milliliter conventional release eye suspension (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Dexamethasone ophthalmic preparation Inferred relationship Some
    dexamethasonnatriumphosphat 0,1 % opløsning The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Dexamethasone ophthalmic preparation Inferred relationship Some
    dexamethasonnatriumphosphat 0,1 mg/ml opløsning The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Dexamethasone ophthalmic preparation Inferred relationship Some
    Dexamethasone sodium phospha 0.05% The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Dexamethasone ophthalmic preparation Inferred relationship Some
    dexamethasonnatriumphosphat 1 mg/ml opløsning The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Dexamethasone ophthalmic preparation Inferred relationship Some
    Dexamethasone phosphate + dexamethasone sodium phospha 1mg/0ns solution The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Dexamethasone ophthalmic preparation Inferred relationship Some
    dexamethasonnatriumphosphat + lidocainhydrochlorid 4 mg/10 mg/ml injektionsvæske, opløsning The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Dexamethasone ophthalmic preparation Inferred relationship Some
    Dexamethasone sodium phospha + neomycin sulfate 0ns/0ns solution The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Dexamethasone ophthalmic preparation Inferred relationship Some
    dexamethasonnatriumphosphat 1 mg +neomycinsulfat 3,5 mg opløsning The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Dexamethasone ophthalmic preparation Inferred relationship Some
    Product containing dexamethasone in ocular dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Dexamethasone ophthalmic preparation Inferred relationship Some
    dexamethasonnatriumphosphat The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Dexamethasone ophthalmic preparation Inferred relationship Some

    Reference Sets

    Concept inactivation indicator reference set

    GB English

    US English

    SAME AS association reference set (foundation metadata concept)

    Back to Start